Opportunity Information: Apply for RFA DA 15 004
Apply for RFA DA 15 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NIDA Avant Garde Award Program for HIV/AIDS and Drug Use Research (DP1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Feb 13, 2014 and posted on Feb 13, 2014.
- Applicants must submit their applications by Jul 29, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: County governments Public and State controlled institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Special district governments Independent school districts For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIDA Avant Garde Award Program for HIV/AIDS and Drug Use Research (DP1), released by the National Institutes of Health through the National Institute on Drug Abuse (NIDA), is a discretionary grant opportunity designed to back exceptionally creative scientists pursuing bold, high impact ideas at the intersection of HIV/AIDS and drug use. The central goal is to spark research that can open entirely new areas of HIV/AIDS investigation and/or create new pathways for preventing and treating HIV among people who use drugs. In this program, "avant garde" is used in the literal sense: projects are expected to be highly innovative and potentially transformative, not incremental extensions of existing work. A key expectation is that the proposed concepts and approaches should be substantially different from what the investigator has been doing and from what the broader field is already pursuing.
The scientific emphasis is on innovative basic research with a clear line of sight to improved public health impact for drug-using populations affected by HIV. The announcement highlights several example directions, including work that could lead to improved preventive interventions or therapies, creative new strategies to reduce or prevent HIV transmission, novel approaches to improve outcomes for people living with HIV, and ambitious ideas aimed at eradicating HIV or significantly improving quality of life. While the program is rooted in basic research, it is framed around big, field-shaping advances that could ultimately shift prevention and treatment paradigms, particularly where drug use increases risk, complicates treatment, or worsens outcomes.
Administratively, this opportunity is identified as Funding Opportunity Number RFA-DA-15-004 and uses the DP1 activity code, which is commonly associated with high risk, high reward, investigator-driven research concepts. It falls under the Health and Education activity areas and is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The opportunity does not require cost sharing or matching funds, which can make it more accessible to a wide range of institutions and organizations.
In terms of funding scale, the opportunity listed an estimated total program funding amount of $2,000,000 and an award ceiling of $500,000. These figures indicate a selective program designed to concentrate resources on a limited number of especially promising, unconventional projects rather than spread funding across many smaller, conventional studies. The posting and creation date were February 13, 2014, with an original and current closing date of July 29, 2016, and an archive date of August 29, 2016, meaning the specific announcement is now closed, though similar programs may reappear under updated solicitations.
Eligibility is broad and includes many types of domestic U.S. organizations and governments, such as public and private institutions of higher education, state and local governments (including county, city/township, special district governments, and independent school districts), nonprofits with or without 501(c)(3) status, public housing authorities/Indian housing authorities, small businesses, and for-profit organizations other than small businesses. The eligibility language also explicitly extends to a wide range of specialized institutions and communities, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and regional organizations. Importantly, non-U.S. entities are eligible to apply, including foreign organizations and foreign institutions, and non-U.S. components of U.S. organizations are also eligible. Foreign components, as defined by NIH policy, are allowed, reinforcing that the program is open to global expertise when it aligns with the scientific goals.
For applicants seeking the official details, the full announcement was hosted on the NIH grants website at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-004.html, and the notice provides NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues (FBOWebmaster@OD.NIH.GOV). Overall, this funding opportunity is best understood as a targeted, high risk, high reward mechanism aimed at empowering standout investigators to pursue unconventional, potentially field-changing ideas that can meaningfully alter the landscape of HIV prevention, transmission reduction, treatment, and long-term outcomes for people affected by drug use.
FAQs: NIDA Avant Garde Award Program for HIV/AIDS and Drug Use Research (DP1) - RFA-DA-15-004
What is this grant opportunity?
The NIDA Avant Garde Award Program for HIV/AIDS and Drug Use Research (DP1) is a discretionary National Institutes of Health (NIH) funding opportunity from the National Institute on Drug Abuse (NIDA). It is designed to support exceptionally creative scientists pursuing bold, high-impact ideas at the intersection of HIV/AIDS and drug use.
What is the main goal of the Avant Garde Award program?
The central goal is to spark research that can open entirely new areas of HIV/AIDS investigation and/or create new pathways for preventing and treating HIV among people who use drugs.
What does "avant garde" mean in this program?
In this program, "avant garde" is meant literally. Projects are expected to be highly innovative and potentially transformative, not incremental extensions of existing work.
How innovative does the proposed research need to be?
A key expectation is that the proposed concepts and approaches should be substantially different from what the investigator has been doing and from what the broader field is already pursuing.
What types of research does the program emphasize?
The emphasis is on innovative basic research with a clear line of sight to improved public health impact for drug-using populations affected by HIV.
What kinds of project ideas are highlighted as examples?
The announcement highlights example directions such as work that could lead to improved preventive interventions or therapies, creative new strategies to reduce or prevent HIV transmission, novel approaches to improve outcomes for people living with HIV, and ambitious ideas aimed at eradicating HIV or significantly improving quality of life.
Is the program focused on basic research or applied research?
The program is rooted in basic research, but it is framed around big, field-shaping advances that could ultimately shift prevention and treatment paradigms, particularly where drug use increases risk, complicates treatment, or worsens outcomes.
Which agency and institute are offering this opportunity?
The opportunity was released by the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA).
What is the Funding Opportunity Number (FOA) for this announcement?
The Funding Opportunity Number is RFA-DA-15-004.
What is the activity code for this award?
The opportunity uses the DP1 activity code, which is commonly associated with high risk, high reward, investigator-driven research concepts.
What activity areas does this opportunity fall under?
It falls under the Health and Education activity areas.
What is the CFDA number for this program listing?
The listing is under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching funds.
How much total funding was estimated for the program?
The estimated total program funding amount listed was $2,000,000.
What is the award ceiling for an individual award?
The award ceiling listed was $500,000.
What do the funding amounts suggest about the program?
They suggest a selective program designed to concentrate resources on a limited number of especially promising, unconventional projects rather than spread funding across many smaller, conventional studies.
When was this opportunity posted?
The posting and creation date was February 13, 2014.
What were the closing and archive dates?
The original and current closing date was July 29, 2016, and the archive date was August 29, 2016.
Is this specific funding opportunity still open?
No. Based on the listed closing and archive dates, this specific announcement is closed.
Can similar opportunities appear again in the future?
Yes. While this particular announcement is closed, the description notes that similar programs may reappear under updated solicitations.
What types of U.S. organizations are eligible to apply?
Eligibility includes many types of domestic U.S. organizations and governments, such as public and private institutions of higher education, state governments, local governments (including county, city/township, special district governments, and independent school districts), nonprofits with or without 501(c)(3) status, public housing authorities/Indian housing authorities, small businesses, and for-profit organizations other than small businesses.
Are community-based or faith-based organizations included in eligibility?
Yes. The eligibility language explicitly includes faith-based or community-based organizations and regional organizations.
Are minority-serving institutions specifically included in eligibility?
Yes. Eligibility explicitly extends to institutions and communities including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Are non-U.S. organizations eligible to apply?
Yes. Non-U.S. entities are eligible to apply, including foreign organizations and foreign institutions.
Are non-U.S. components of U.S. organizations eligible?
Yes. Non-U.S. components of U.S. organizations are eligible.
Are foreign components allowed under NIH policy?
Yes. Foreign components, as defined by NIH policy, are allowed, reinforcing that the program is open to global expertise when it aligns with the scientific goals.
Where can applicants find the official announcement?
The full announcement was hosted on the NIH grants website at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-004.html
Who is listed as a contact for access or linking issues?
The notice provides NIH Office of Extramural Research (OER) webmaster contact information for access or linking issues: FBOWebmaster@OD.NIH.GOV
What kind of investigator is this award intended to support?
It is aimed at empowering standout investigators to pursue unconventional, potentially field-changing ideas that can meaningfully alter the landscape of HIV prevention, transmission reduction, treatment, and long-term outcomes for people affected by drug use.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: BLM OR WA Cooperative Ecosystems Studies Unit (CESU) Panther Creek Weather Modeling
Previous opportunity: Fiscal Year 2014 Chesapeake Bay Fisheries Science Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 15 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 15 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01) Apply for RFA HG 14 020 Funding Number: RFA HG 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Early Phase Clinical Trials in Imaging and Image Guided Interventions (R21) Apply for PAR 14 013 Funding Number: PAR 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Family Centered Self Management of Chronic Conditions (R21) Apply for PA 14 113 Funding Number: PA 14 113 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Family Centered Self Management of Chronic Conditions (R01) Apply for PA 14 112 Funding Number: PA 14 112 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21) Apply for PAR 14 105 Funding Number: PAR 14 105 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03) Apply for PAR 14 104 Funding Number: PAR 14 104 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01) Apply for PAR 14 106 Funding Number: PAR 14 106 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Additional Research Training Slots for NIDA Supported NRSA Institutional Training (T32) Grants (Admin Supp) Apply for PAR 14 115 Funding Number: PAR 14 115 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01) Apply for PAR 14 116 Funding Number: PAR 14 116 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Accelerating Improvements in the HIV Care Continuum (R01) Apply for PA 14 132 Funding Number: PA 14 132 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prevention and Treatment of Substance Using Populations with or at Risk for HCV (R34) Apply for PA 14 135 Funding Number: PA 14 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Prevention and Treatment of Substance Using Populations with or at Risk for HCV (R21) Apply for PA 14 136 Funding Number: PA 14 136 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prevention and Treatment of Substance Using Populations with or at Risk for HCV (R01) Apply for PA 14 137 Funding Number: PA 14 137 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Research (CPAR) (R21) Apply for PA 14 141 Funding Number: PA 14 141 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Community Partnerships to Advance Research (CPAR) (R01) Apply for PA 14 142 Funding Number: PA 14 142 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Research (CPAR) (R15) Apply for PA 14 140 Funding Number: PA 14 140 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Additional Research Training Positions for NIAAA , NIDA , or NCI Supported NRSA Institutional Training (T32) Grants (Admin Supp) Apply for PA 14 146 Funding Number: PA 14 146 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) Apply for PAR 14 152 Funding Number: PAR 14 152 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 14 160 Funding Number: PAR 14 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03) Apply for PA 14 164 Funding Number: PA 14 164 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 15 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.